Celsius shares are up more than 30% after its quarterly results topped estimates and it announced plans to buy drink maker ...
Shares of Acelyrin climbed after the company said it has received an unsolicited indication of interest from Concentra Biosciences for an acquisition at $3 a share. The stock was up 14% at $2.48 in ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results